- Home
- BELFA vs NAGE Comparison
BELFA vs NAGE Comparison
Compare BELFA & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BELFA
- NAGE
- Stock Information
- Founded
- BELFA 1949
- NAGE 1999
- Country
- BELFA United States
- NAGE United States
- Employees
- BELFA N/A
- NAGE N/A
- Industry
- BELFA
- NAGE Medicinal Chemicals and Botanical Products
- Sector
- BELFA
- NAGE Health Care
- Exchange
- BELFA Nasdaq
- NAGE Nasdaq
- Market Cap
- BELFA 948.4M
- NAGE 861.0M
- IPO Year
- BELFA N/A
- NAGE N/A
- Fundamental
- Price
- BELFA $63.49
- NAGE $11.73
- Analyst Decision
- BELFA
- NAGE Strong Buy
- Analyst Count
- BELFA 0
- NAGE 2
- Target Price
- BELFA N/A
- NAGE $12.00
- AVG Volume (30 Days)
- BELFA 3.8K
- NAGE 1.2M
- Earning Date
- BELFA 07-23-2025
- NAGE 05-07-2025
- Dividend Yield
- BELFA 0.38%
- NAGE N/A
- EPS Growth
- BELFA N/A
- NAGE N/A
- EPS
- BELFA 3.42
- NAGE 0.18
- Revenue
- BELFA $558,940,000.00
- NAGE $107,925,000.00
- Revenue This Year
- BELFA $18.21
- NAGE $25.46
- Revenue Next Year
- BELFA $7.91
- NAGE $21.72
- P/E Ratio
- BELFA $18.58
- NAGE $65.43
- Revenue Growth
- BELFA N/A
- NAGE 29.77
- 52 Week Low
- BELFA $53.95
- NAGE $2.31
- 52 Week High
- BELFA $106.93
- NAGE $11.79
- Technical
- Relative Strength Index (RSI)
- BELFA 42.15
- NAGE N/A
- Support Level
- BELFA $63.01
- NAGE N/A
- Resistance Level
- BELFA $66.10
- NAGE N/A
- Average True Range (ATR)
- BELFA 1.16
- NAGE 0.00
- MACD
- BELFA -0.36
- NAGE 0.00
- Stochastic Oscillator
- BELFA 7.10
- NAGE 0.00
About BELFA Bel Fuse Inc.
Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.
About NAGE Niagen Bioscience Inc. Common Stock
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.